| | | Sponsored by: The Janssen Pharmaceutical Companies of Johnson & Johnson Janssen to highlight data from study of investigational bispecific antibody in patients with advanced non-small cell lung cancer with a certain genetic mutation. Click here to learn more. |
|
|---|
|
| | | Sponsored by: HOOKIPA Pharma Inc. Join us to review the first-in-human Phase 1 study of novel arenaviral therapeutics, HB-201 & HB-202, in advanced HPV16+ cancer patients (ASCO oral #2502). The program will highlight antigen-specific CD8+ T cell, anti-tumor activity and tolerability data, as well as implications for the future. Read more. |
|
|---|
|
| | | Sponsored by: Parexel The global biotech industry is booming with an estimated market size of more than $300 billion, and emerging biotechs are driving a large portion of innovation and development. To learn more, download the whitepaper. |
|
|---|
|
| | | Sponsored by: DocuSign At each step in the product life cycle, pharma, biotech and medtech companies need to engage with third parties to develop, manufacture and sell their drugs, diagnostics and devices. With lives at stake and multiple players pursuing opportunities, companies that close deals quickly have a competitive edge. Yet, each contract exposes a company to an array of major third-party risks, creating a need for systems that support both speed and quality. Download this playbook to learn more. |
|
|---|
|
| | | Presented by: Lonza
June 24, 2021 | 11am ET / 8am PT This webinar focuses on manufacturing aspects that enable successful development and scale-up of the micronization process. Technical issues that must be investigated for successful development of effective API micronization will be explored. An overview of micronization and typical scale-up challenges will be presented along with a robust process development strategy to ensure critical-to-quality attributes are maintained. Register Now. |
|
|---|
|
|
|
